Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2013

Open Access 01-12-2013 | Primary research

Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer

Authors: Lihua Xu, Xiangmin Ding, Huo Tan, Jianjun Qian

Published in: Cancer Cell International | Issue 1/2013

Login to get access

Abstract

Background

B7-H3 and matrix metalloproteinases 2 (MMP-2) are reported highly expressed in malignant tumor, we investigate the relationship between B7-H3 expression and MMP-2 on malignant behavior and prognosis predictable value in pancreatic cancer.

Methods

We tested the expressions of B7-H3 and MMP-2 protein in 45 pancreatic surgical resected cancer samples; meanwhile, the clinicopathological data of enrolled patients were obtained for correlation analysis to obtain their relationship with pancreatic cancer progress.

Results

The expression of B7-H3 was up-regulated with infiltrating depth, lymph node metastasis and TNM stage (P < 0.01). Positive expression rate of MMP-2 in pancreatic cancer tissues was 44.35%, whereas negative in normal pancreatic tissues. Multivariate analysis of Logistic regression showed B7-H3 and MMP-2 expressions were hazardous makers correlated with infiltrating depth (P < 0.05).

Conclusion

Our study showed combined detections of B7-H3 and MMP2 protein expression could identify patients at high risk in disease recurrence and prognosis more efficiently.
Appendix
Available only for authorised users
Literature
1.
Laheru D, Jaffee EM: Immunotherapy for pancreatic cancer - science driving clinical progress. Nat Rev Cancer. 2005, 5: 459-467.CrossRefPubMed
2.
Chen WQ, Zheng RS, Zhang SW, Li N, Zhao P, Li GL, Wu LY, He J: Report of incidence and mortality in china cancer registries, 2008. Chin J Cancer Res. 2012, 24: 171-180. 10.1007/s11670-012-0171-2.PubMedCentralCrossRefPubMed
3.
Labianca R, Merelli B, Mosconi S: Treatment of advanced pancreatic cancer. Ann Oncol. 2012, 23 (Suppl 10): x139-x140. 10.1093/annonc/mds355.CrossRefPubMed
4.
5.
Gonda TA, Lucas A, Saif MW: Screening and detection of pancreatic cancer. Highlights from the “2011 ASCO Annual Meeting”. Chicago, IL, USA; June 3–7, 2011. JOP. 2011, 12: 322-324.PubMedCentralPubMed
6.
Wang J, Liu L, Xie L, Xiang G, Zhou Y: Induction of differentiation-specific miRNAs in TPA-induced myeloid leukemia cells through MEK/ERK activation. Int J Mol Med. 2013, 31: 59-66.PubMed
7.
Xu YH, Zhang GB, Wang JM, Hu HC: B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis. Saudi Med J. 2010, 31: 980-986.PubMed
8.
Yamato I, Sho M, Nomi T, Akahori T, Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H, Nakajima Y: Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer. 2009, 101: 1709-1716. 10.1038/sj.bjc.6605375.PubMedCentralCrossRefPubMed
9.
Zhang G, Xu Y, Lu X, Huang H, Zhou Y, Lu B, Zhang X: Diagnosis value of serum B7-H3 expression in non-small cell lung cancer. Lung Cancer. 2009, 66: 245-249. 10.1016/j.lungcan.2009.01.017.CrossRefPubMed
10.
Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S, Natsugoe S: B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci. 2011, 102: 1019-1024. 10.1111/j.1349-7006.2011.01877.x.CrossRefPubMed
11.
Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu KF, Zhao JM, Zhang GB, Zhang XG: Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol. 2006, 12: 457-459.PubMedCentralPubMed
12.
Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, Maelandsmo GM, Fodstad O: B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes. Int J Cancer. 2012, 130: 2282-2290. 10.1002/ijc.26238.CrossRefPubMed
13.
Kessenbrock K, Plaks V, Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010, 141: 52-67. 10.1016/j.cell.2010.03.015.PubMedCentralCrossRefPubMed
14.
Curran S, Murray GI: Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 2000, 36: 1621-1630. 10.1016/S0959-8049(00)00156-8.CrossRefPubMed
15.
Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2: 161-174. 10.1038/nrc745.CrossRefPubMed
16.
Kjellman M, Enberg U, Hoog A, Larsson C, Holst M, Farnebo LO, Sato H, Backdahl M: Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA: expressed in adrenocortical cancers but not in adenomas. World J Surg. 1999, 23: 237-242. 10.1007/PL00013183.CrossRefPubMed
17.
Dalberg K, Eriksson E, Enberg U, Kjellman M, Backdahl M: Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. World J Surg. 2000, 24: 334-340. 10.1007/s002689910053.CrossRefPubMed
18.
Ferretti S, Patriarca S, Carbone A, Zanetti R: [TNM classification of malignant tumours, VII edition 2009. Changes and practical effects on cancer epidemiology]. Epidemiol Prev. 2009, 2010 (34): 125-128.
19.
Erkan M, Kleeff J, Esposito I, Giese T, Ketterer K, Buchler MW, Giese NA, Friess H: Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene. 2005, 24: 4421-4432. 10.1038/sj.onc.1208642.CrossRefPubMed
20.
Guo RP, Zhong C, Shi M, Zhang CQ, Wei W, Zhang YQ, Li JQ: Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2006, 132: 547-555. 10.1007/s00432-006-0097-5.CrossRefPubMed
21.
Li H, Wang C, Guo G, Gao C, Wu Y, Chen Y: The characteristic expression of B7-associated proteins in Langerhans cell sarcoma. Acta Histochem. 2012, 114: 733-743. 10.1016/j.acthis.2011.12.010.CrossRefPubMed
22.
Zhao X, Li DC, Zhu XG, Gan WJ, Li Z, Xiong F, Zhang ZX, Zhang GB, Zhang XG, Zhao H: B7-H3 overexpression in pancreatic cancer promotes tumor progression. Int J Mol Med. 2013, 31: 283-291.PubMedCentralPubMed
23.
Leach DR, Krummel MF, Allison JP: Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996, 271: 1734-1736. 10.1126/science.271.5256.1734.CrossRefPubMed
24.
Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, Wang X: B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer. 2006, 53: 143-151. 10.1016/j.lungcan.2006.05.012.CrossRefPubMed
Metadata
Title
Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer
Authors
Lihua Xu
Xiangmin Ding
Huo Tan
Jianjun Qian
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2013
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-13-81

Other articles of this Issue 1/2013

Cancer Cell International 1/2013 Go to the issue

Primary research

MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN

Primary research

Depleting NFAT1 expression inhibits the ability of invasion and migration of human lung cancer cells

Primary research

RETRACTED ARTICLE: Diagnosis, classification and grading of canine mammary tumours as a model to study human breast cancer: an Clinico-Cytohistopathological study with environmental factors influencing public health and medicine

Primary research

Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells

Primary research

MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia

Primary research

Antiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits